Editorial: Metabolic reprogramming for acquiring therapeutic resistance in glioblastoma
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2023-07-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2023.1220063/full |
| _version_ | 1797779998399004672 |
|---|---|
| author | Tsung-I Hsu Tsung-I Hsu Tsung-I Hsu Tsung-I Hsu |
| author_facet | Tsung-I Hsu Tsung-I Hsu Tsung-I Hsu Tsung-I Hsu |
| author_sort | Tsung-I Hsu |
| collection | DOAJ |
| first_indexed | 2024-03-12T23:38:26Z |
| format | Article |
| id | doaj.art-18f8dfae522b4ca2ab2f0eb57022bbce |
| institution | Directory Open Access Journal |
| issn | 2234-943X |
| language | English |
| last_indexed | 2024-03-12T23:38:26Z |
| publishDate | 2023-07-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Oncology |
| spelling | doaj.art-18f8dfae522b4ca2ab2f0eb57022bbce2023-07-15T03:24:28ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2023-07-011310.3389/fonc.2023.12200631220063Editorial: Metabolic reprogramming for acquiring therapeutic resistance in glioblastomaTsung-I Hsu0Tsung-I Hsu1Tsung-I Hsu2Tsung-I Hsu3Ph.D. Program in Medical Neuroscience, College of Medical Science and Technology, Taipei Medical University and National Health Research Institutes, Taipei, TaiwanInternational Master Program in Medical Neuroscience, College of Medical Science and Technology, Taipei Medical University, Taipei, TaiwanTaipei Medical University Research Center of Neuroscience, Taipei, TaiwanTaipei Medical University Research Center of Cancer Translational Medicine, Taipei, Taiwanhttps://www.frontiersin.org/articles/10.3389/fonc.2023.1220063/fullmetabolic reprogrammingtherapeutic resistanceglioblastomatemozolomidemass spectrometryorexin A |
| spellingShingle | Tsung-I Hsu Tsung-I Hsu Tsung-I Hsu Tsung-I Hsu Editorial: Metabolic reprogramming for acquiring therapeutic resistance in glioblastoma Frontiers in Oncology metabolic reprogramming therapeutic resistance glioblastoma temozolomide mass spectrometry orexin A |
| title | Editorial: Metabolic reprogramming for acquiring therapeutic resistance in glioblastoma |
| title_full | Editorial: Metabolic reprogramming for acquiring therapeutic resistance in glioblastoma |
| title_fullStr | Editorial: Metabolic reprogramming for acquiring therapeutic resistance in glioblastoma |
| title_full_unstemmed | Editorial: Metabolic reprogramming for acquiring therapeutic resistance in glioblastoma |
| title_short | Editorial: Metabolic reprogramming for acquiring therapeutic resistance in glioblastoma |
| title_sort | editorial metabolic reprogramming for acquiring therapeutic resistance in glioblastoma |
| topic | metabolic reprogramming therapeutic resistance glioblastoma temozolomide mass spectrometry orexin A |
| url | https://www.frontiersin.org/articles/10.3389/fonc.2023.1220063/full |
| work_keys_str_mv | AT tsungihsu editorialmetabolicreprogrammingforacquiringtherapeuticresistanceinglioblastoma AT tsungihsu editorialmetabolicreprogrammingforacquiringtherapeuticresistanceinglioblastoma AT tsungihsu editorialmetabolicreprogrammingforacquiringtherapeuticresistanceinglioblastoma AT tsungihsu editorialmetabolicreprogrammingforacquiringtherapeuticresistanceinglioblastoma |